MedPath

Mindfulness for People With Incurable Cancer

Not Applicable
Completed
Conditions
Cancer
Interventions
Behavioral: Mindfulness for health
Registration Number
NCT03446092
Lead Sponsor
Lancaster University
Brief Summary

The study will investigate whether a mindfulness course can help people with incurable cancer who are seen by oncologists in a particular National Health Service Hospital Trust in the United Kingdom.

Detailed Description

It can be hard to come to terms with living with a life limiting condition such as incurable cancer and individuals are at risk of experiencing high levels of psychological distress, which can often be overlooked when the focus is on managing physical symptoms.

Mindfulness-based interventions have been shown to be helpful in reducing distress for people with cancer generally. This pilot study will use an established mindfulness programme called mindfulness for health with people with cancer which is incurable to see if this type of intervention is acceptable and useful for this group of people.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Deemed by the oncologist to have incurable cancer
  • Patient of the University Hospitals of Morecambe Bay NHS Foundation Trust
  • Treated by an oncologist
  • Believe they are able to commit to attending most of the mindfulness course sessions
  • Oncologist assesses they are well enough to participate in the intervention
Read More
Exclusion Criteria
  • Having any other condition or difficulty which the medical team thinks would compromise their participation in the study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mindfulness groupMindfulness for healthGroup will receive mindfulness intervention
Primary Outcome Measures
NameTimeMethod
Acceptability and usefulness of intervention for participantsWithin 4 weeks of the end of the intervention

This will be a qualitative outcome, collected via semi-structured interview

Secondary Outcome Measures
NameTimeMethod
Change in quality of lifeCollected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention

Using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores

Change in depression anxiety and stressCollected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention

Using the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.

Change in depression anxiety and stress-3 monthsCollected before the intervention (up to 4 weeks before the intervention) and 3 months after the end of the intervention

Using the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.

Change in mindfulness- 3 monthsCollected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention

Using the Five Factor Mindfulness Questionnaire we will measure pre-post change scores

Acceptability and usefulness of intervention for participants- 3 months3 months following completion of the intervention

This will be a qualitative outcome, collected via semi-structured interview

Change in mindfulnessCollected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention

Using the Five Factor Mindfulness Questionnaire we will measure pre-post change scores.

Change in quality of life - 3 monthsCollected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention

Using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores

Trial Locations

Locations (1)

Royal Lancaster Infirmary

🇬🇧

Lancaster, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath